Clonal hematopoiesis is associated with improved survival in patients with metastatic colorectal cancer from the FIRE-3 trial

Blood. 2022 Mar 10;139(10):1593-1597. doi: 10.1182/blood.2021014108.

Christopher Maximilian Arends¹, Savvina Dimitriou¹, Arndt Stahler^{1

2}, Raphael Hablesreiter¹, Paulina M Strzelecka¹, Catarina M Stein¹, Marlon Tilgner¹, Ryunosuke Saiki³, Seishi Ogawa³, Lars Bullinger^{1

4

5}, Dominik P Modest¹, Sebastian Stintzing^{1

4

5}, Volker Heinemann², Frederik Damm^{1

4

5}

¹ Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
² Department of Medical Oncology and Comprehensive Cancer Center, University Hospital Grosshadern, Munich, Germany.
³ Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
⁴ German Cancer Consortium, Berlin, Germany; and.
⁵ German Cancer Research Center, Heidelberg, Germany.

No abstract available

Publication types